Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

blank

 

Recent News and Articles on the Keywords: pass ms + more than + pass  Related to the article below (Last Update: 5/5/2008)

Mums keen to pass on advice
Port Macquarie News, Australia -
The group has more than 1000 volunteer breastfeeding counsellors around the country who have undertaken an extensive training course to provide help to ...
Thousands walk to help fight MS
Meriden Record-Journal, CT -
... Hope," which raised more than $55000 over eight years, according to Butler. Hayley was planning to attend Dartmouth College in the fall and pass on her ...
Travelers 2008 MS Walk supports a cause and tragedy WTNH
all 3 news articles »
Mull Rescue Plans
Wall Street Journal -
Picking off a few seats could significantly improve Democrats' ability to pass legislation. Whether the federal government should do more to rescue ...
Strategies for stretching your spa dollars
Dallas Morning News, TX - May 4, 2008
At the Sheraton Wild Horse Pass Resort & Spa in Chandler, Ariz., you do not even have to book a treatment to use the spa's pools, Jacuzzis, steam rooms, ...

Wall Street Journal
Derby Death Stirs Call for Change
Wall Street Journal -
"Many of the family's descendants tend to pass on unsoundness," she said, with many suffering similar injuries because their legs have "heavy muscling" that ...
?Don?t dodge Women?s Bill any further?
Hindu, India - 15 minutes ago
... though women had been fighting for this just demand for more than 12 years, successive governments have failed to pass the Bill. ...
GSIS planning to file fraud charges against Meralco
Inquirer.net, Philippines -
How sure are we that this is not just a ploy of management to pass on some illegal consumption of management to consumers?? Garcia asked. ...
As non-traditional treatments gain wider acceptance in the ...
San Francisco Chronicle,  USA -
Within acupuncture itself, herbology, counseling, exercise science, nutrition and massage therapy are studied before a degree and an opportunity to pass a ...
Pembroke's Sarah Boudens to compete in Beijing
Pembroke Daily Observer,  Canada -
Slalom kayaking compares to slalom skiing, where racers have two attempts at a course and pass through gates, being assessed penalties for mistakes such as ...
Taking the Long View
Wall Street Journal -
One of my sons said to me: "Dad, I have to pass a swimming test to graduate from college, but I don't have to know anything about credit cards and checking ...
Source: Google News

Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998 … -
… , G Rothrock, NL Barrett, M Pass, C Lexau, B … - JAMA, 2001 - Am Med Assoc
... Gretchen Rothrock, MPH ; Nancy L. Barrett, MS, MPH ; Margaret Pass, MS, CIC ; Catherine
Lexau ... Since 1995, 425 patients (3%) had more than 1 episode of invasive ...

Interactive multi-pass programmable shading -
MS Peercy, M Olano, J Airey, PJ Ungar - Proceedings of the 27th annual conference on Computer …, 2000 - portal.acm.org
... reduced and one after. The iburg-like label/reduce tool proved useful for
more than just final pass selection. We use it for shader ...

Macrolide Resistance Among Invasive Streptococcus pneumoniae Isolates -
… Gay, DS Stephens, DJ Vugia, M Pass, S Johnson, NL … - JAMA, 2001 - Am Med Assoc
... MD ; Duc J. Vugia, MD,MPH ; Margaret Pass, MS ; Susan Johnson ; Nancy L. Barrett,
MS,MPH ; William ... In 1999, M phenotype strains were more often from ...

Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human … -
… Hubbell, E Robinson, M Mittmann, MS Morris, N Shen … - Science, 1998 - sciencemag.org
... products were subjected to single-pass DNA sequencing ... the expected sequence should
hybridize more strongly to the perfectly complementary probe than to the ...

42%-efficient single-pass cw second-harmonic generation in periodically poled lithium niobate -
GD Miller, RG Batchko, WM Tulloch, DR Weise, MM … - Optics Letters, 1997 - OSA
... it to 0 kV mm over 60 ms to prevent ... The conversion efficiency for cw single-pass
Nd:YAG SHG was 42 ... This conversion efficiency is more than an order of magnitude ...

Accessing Genetic Information with High-Density DNA Arrays -
… , J Winkler, DJ Lockhart, MS Morris, SPA Fodor - Science, 1996 - sciencemag.org
... filtered by a dichroic beamsplitter (555 nm) and a band-pass filter (555 ... Mitochondrial
DNA populations can contain more than one sequence type, in a condition ...

Market share and exchange rate pass-through in world automobile trade -
RC Feenstra, JE Gagnon, MM Knetter - Journal of International Economics, 1996 - Elsevier
... can be obtained if one is willing to make a more restrictive assumption ... elasticity
will be minimized at a total market share of MS > l/2, and the pass-through ...

A design of the low-pass filter using the novel microstrip defectedground structure -
D Ahn, JS Park, CS Kim, J Kim, Y Qian, T Itoh - Microwave Theory and Techniques, IEEE Transactions on, 2001 - ieeexplore.ieee.org
... low-pass filters show more than 20-dB filters up to 8 ... bandgap and its application
for the low-pass filter design ... He received the BS, MS, and Ph.D. degrees from ...

… in Individual Fibroblasts Cell-Autonomous and Self-Sustained Oscillators Pass Time to Daughter … -
E Nagoshi, C Saini, C Bauer, T Laroche, F Naef, U … - Cell, 2004 - Elsevier
... 4.6 days) detected by using a low-pass filter ... of these repressor proteins is attained
more rapidly ... cells were illuminated every 30 min for 430 ms (excitation at ...

A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance … -
JHS Cullen, MA Horsfield, CR Reek, GR Cherryman, … - Journal of the American College of Cardiology, 1999 - Am Coll Cardio Found
... the wash-in portion of a first-pass bolus study ... measurements is currently difficult
(10), and more research is ... With the inversion time of 300 ms, myocardial R ...

Source: Google Scholar

Dads More Likely Than Moms to Pass on MS

Men with multiple sclerosis are more than twice as likely than women with the illness to pass it on to their children, U.S. researchers report.

"When we looked at a large population of MS patients, when there was a parent and a child who had MS in a family, the child with MS got the disease twice as often from the father rather than the mother," researcher Dr. Brian Weinshenker, a Mayo Clinic neurologist, said in a prepared statement.

Reporting in the July 25 issue of Neurology, Weinshenker and his colleagues theorized that this may be because men may have a greater "genetic load" of MS genes compared to women.

"The hypothesis of this study is that men are more resistant to MS, so they need stronger or a larger number of genes in order to develop MS, and then pass these genes to their children," study author Dr. Orhun Kantarci, a Mayo Clinic neurologist, said in a prepared statement.

The fact that men are more likely to pass MS to their children is not easily explained by hormonal differences between women and men or by genes on the sex chromosomes, Kantarci said.

The findings shouldn't affect how men with MS are counseled about the risk to their children, the researchers said. A child with an affected parent has about a 20-fold increased risk of MS. But the additional risk of having a father with the disease is not enough to change current patient counseling methods.

"The over-transmission by men is primarily of interest to scientists studying the mechanisms of genetic transmission of MS susceptibility," Kantarci said. The finding "may indicate that nontraditional, or so-called epigenetic factors, play some role in the transmission of MS," he theorized.

Eighty-five percent of MS cases have no known cause. Among 15 percent of MS patients, a family member within a generation is also affected by the disease. In familial cases, no single gene has been identified that strongly predisposes a person to MS.

Tamoxifen Doesn't Extend Life for Most Women at High Risk for Breast Cancer

  MONDAY, July 24 (HealthDay News) -- Women at risk for breast cancer or breast cancer recurrence are routinely prescribed tamoxifen to help lower that risk, but a new study suggests the drug will not boost the life expectancy of many women who take it.

Specifically, women at high risk for breast cancer but without any prior history of the disease may not benefit from use of the drug in terms of extended life span, researchers found.

They also found the drug to be extraordinarily expensive from a public policy point of view, costing up to $1.3 million per year of life saved.

"If someone was on the lower end of the risk threshold, I would say the benefits of taking tamoxifen in terms of mortality are not there," said lead researcher Dr. Joy Melnikow, professor of family and community medicine at the University of California Davis, Sacramento.

Her team published its findings Monday in the Sept. 1 issue of the journal Cancer.

First approved in 1998 by the U.S. Food and Drug Administration to help prevent breast cancer in women at high risk for the disease, "Tamoxifen [brand named Nolvadex] has been around a long time," Melnikow explained.

The drug works by interfering with the activity of the hormone estrogen, thus reducing the chances of developing breast cancer. The FDA's approval for preventive use was aimed at women with at least a 1.67 percent chance of developing the disease over the next five years -- the threshold for "high risk." The average 60-year-old white woman carries this level of risk, Melnikow said.

The new analysis tackled an as yet unanswered question: Whether tamoxifen does, in fact, lower death rates for high-risk women who take it to prevent breast cancer.

To calculate the drug's effectiveness, Melnikow's team developed a mathematical model that followed a hypothetical group of 50-year-old women to an endpoint of death or 100 years of age.

The researchers reported that tamoxifen would only extend life expectancy when a woman's five-year risk of developing breast cancer reaches about 3 percent or more.

"If women are near that threshold [of 1.67 percent], at the lower end of the high-risk range, the effect of tamoxifen on mortality from breast cancer and overall [causes] was extremely small or negligible," Melnikow said.

And tamoxifen is not without its own level of risk. While reducing the chance that a woman at high risk will get breast cancer, the drug can also increase her risk of developing endometrial cancer, cataracts and blood clots.

Melnikow emphasized that the new analysis is only looking at death rates in women at high risk of breast cancer who do not have it -- not for women with a prior history of the disease.

 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 

"We know in women who have had breast cancer and have hormone-positive [tumors], taking tamoxifen improves their survival," Melnikow said. And, she added, it's well known that tamoxifen reduces breast cancer recurrence in women who had breast cancer by 47 percent with five years of treatment. "It's also been proved to reduce the incidence of breast cancer in women at high risk" by about 49 percent, she said.

However, "We took into consideration the fact that the breast cancers that are prevented by tamoxifen are mostly hormone receptor-positive cancer, and those cancers actually have a better prognosis than hormone-receptor negative cancers," Melnikow explained.

In other words, even though the drug may help prevent many cases of more curable hormone receptor-positive cancers, it is not effective in protecting against more deadly receptor-negative tumors. Added to that is the raised risk for endometrial cancer and blood clots among women taking tamoxifen. The end result is no difference in mortality for many high-risk women using the drug, the researchers concluded.

Meanwhile, the mathematical model found that the drug cost as much as $1.3 million per year of life saved, based on the U.S. price of the drug. That's a concern not only for public policy makers, she said, but also for individual women. For example, a patient living in the Sacramento area can expect to pay between $240 and $1,500 per year for tamoxifen.

The bottom line: "For most women, they don't think it is going to help improve survival," said Dr. Herman Kattlove, medical editor for the American Cancer Society who is familiar with the analysis. "If you are in the [high range] of the high-risk group, it may help survival. But 'may' is the operative word." The drug does decrease the chance of getting breast cancer, he added.

"Risk does matter," stressed Dr. Christy Russell, associate professor of medicine at the University of Southern California Keck School of Medicine, Los Angeles, and an American Cancer Society spokeswoman. "Women at the higher [end of] the risk range are more likely to benefit from the tamoxifen, in terms of reducing their risk of dying prematurely from breast cancer," she said.

And even among lower-risk women, she said, "It would be more acceptable to use tamoxifen if she had no uterus, because a lot of the concern about potential deaths revolved around uterine cancer."

 
Continue News With: News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.